Xiaoxin Ma

1.5k total citations
47 papers, 969 citations indexed

About

Xiaoxin Ma is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Xiaoxin Ma has authored 47 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Cancer Research and 13 papers in Obstetrics and Gynecology. Recurrent topics in Xiaoxin Ma's work include Cancer-related molecular mechanisms research (17 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Circular RNAs in diseases (9 papers). Xiaoxin Ma is often cited by papers focused on Cancer-related molecular mechanisms research (17 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Circular RNAs in diseases (9 papers). Xiaoxin Ma collaborates with scholars based in China and United States. Xiaoxin Ma's co-authors include Ting‐Ting Gong, Qi‐Jun Wu, Fanfei Kong, Jian Ma, Cuicui Wang, Hui Yang, Rong Cong, Shulan Zhang, Yizi Wang and Hao Liu and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Annals of Oncology.

In The Last Decade

Xiaoxin Ma

45 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxin Ma China 19 482 425 224 180 164 47 969
Shing Shun N Siu China 9 202 0.4× 351 0.8× 174 0.8× 108 0.6× 59 0.4× 12 712
Petra Kleiblová Czechia 18 463 1.0× 199 0.5× 323 1.4× 107 0.6× 52 0.3× 47 1.0k
Yiran Li China 18 233 0.5× 139 0.3× 120 0.5× 74 0.4× 92 0.6× 44 596
Tetsutaro Hamano Japan 12 204 0.4× 212 0.5× 280 1.3× 120 0.7× 85 0.5× 21 772
Xiong Li China 14 242 0.5× 141 0.3× 122 0.5× 116 0.6× 59 0.4× 49 652
Yuan Zhao China 13 262 0.5× 159 0.4× 72 0.3× 66 0.4× 87 0.5× 44 552
Dong Zhao China 15 197 0.4× 167 0.4× 106 0.5× 263 1.5× 324 2.0× 46 733
Hideaki Tsuyoshi Japan 16 164 0.3× 91 0.2× 76 0.3× 170 0.9× 223 1.4× 42 673
J.W.C.M. Jansen Netherlands 16 234 0.5× 153 0.4× 107 0.5× 214 1.2× 468 2.9× 32 1.0k
Zhihong Niu China 16 267 0.6× 74 0.2× 98 0.4× 138 0.8× 435 2.7× 62 924

Countries citing papers authored by Xiaoxin Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoxin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Ma more than expected).

Fields of papers citing papers by Xiaoxin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Ma. The network helps show where Xiaoxin Ma may publish in the future.

Co-authorship network of co-authors of Xiaoxin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxin Ma. A scholar is included among the top collaborators of Xiaoxin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxin Ma. Xiaoxin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Cuicui & Xiaoxin Ma. (2025). The role of acetylation and deacetylation in cancer metabolism. Clinical and Translational Medicine. 15(1). e70145–e70145. 5 indexed citations
3.
Li, Qing, Fanfei Kong, Rong Cong, et al.. (2023). PVT1/miR-136/Sox2/UPF1 axis regulates the malignant phenotypes of endometrial cancer stem cells. Cell Death and Disease. 14(3). 177–177. 11 indexed citations
4.
Gu, Jiahui, et al.. (2023). ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer. Frontiers in Oncology. 13. 1097015–1097015. 4 indexed citations
5.
Yang, Di, Jian Ma, & Xiaoxin Ma. (2021). CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment. Frontiers in Cell and Developmental Biology. 9. 721676–721676. 15 indexed citations
6.
Ma, Xiaoxin, et al.. (2021). Interaction Between LncRNA and UPF1 in Tumors. Frontiers in Genetics. 12. 624905–624905. 16 indexed citations
7.
8.
Wang, Liya, Xiujie Sheng, Qiming Wang, et al.. (2020). <p>Malignant Ovarian Tumors During Pregnancy: A Multicenter Retrospective Analysis</p>. Cancer Management and Research. Volume 12. 10841–10848. 7 indexed citations
9.
Sun, Hui, Qing Chang, Yashu Liu, et al.. (2020). Adherence to Cancer Prevention Guidelines and Endometrial Cancer Risk: Evidence from a Systematic Review and Dose-Response Meta-analysis of Prospective Studies. Cancer Research and Treatment. 53(1). 223–232. 3 indexed citations
10.
Pan, Xin & Xiaoxin Ma. (2020). A Novel Six-Gene Signature for Prognosis Prediction in Ovarian Cancer. Frontiers in Genetics. 11. 1006–1006. 11 indexed citations
12.
Li, Yibing, et al.. (2020). BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma. Cancer Cell International. 20(1). 490–490. 9 indexed citations
14.
Wang, Wantong, et al.. (2020). High-throughput sequencing study of the effect of transabdominal hysterectomy on intestinal flora in patients with uterine fibroids. BMC Microbiology. 20(1). 98–98. 23 indexed citations
15.
Wang, Zi-Hao, et al.. (2019). Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer. Cancer Cell International. 19(1). 296–296. 59 indexed citations
16.
Wang, Yizi, Fang Ren, Peng Chen, et al.. (2018). Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis. European Journal of Surgical Oncology. 45(3). 301–309. 34 indexed citations
17.
Kong, Fanfei, Jian Ma, Hui Yang, et al.. (2018). Long non-coding RNA PVT1 promotes malignancy in human endometrial carcinoma cells through negative regulation of miR-195-5p. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(10). 1479–1490. 37 indexed citations
18.
Song, Ning, Hao Liu, Xiaoxin Ma, & Shulan Zhang. (2016). Placental Growth Factor Promotes Ovarian Cancer Cell Invasion via ZEB2. Cellular Physiology and Biochemistry. 38(1). 351–358. 14 indexed citations
19.
Gong, Ting‐Ting, et al.. (2015). Age at menarche and endometrial cancer risk: a dose-response meta-analysis of prospective studies. Scientific Reports. 5(1). 14051–14051. 88 indexed citations
20.
Ma, Xiaoxin, et al.. (2010). Effects of HER2 on COX-2/PGE2 /P450arom Signal Pathway in Nude Mice Endometial Model. 39(10). 823–826. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026